Gan Qiao

1.0k total citations
37 papers, 754 citations indexed

About

Gan Qiao is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Gan Qiao has authored 37 papers receiving a total of 754 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Cancer Research. Recurrent topics in Gan Qiao's work include Autophagy in Disease and Therapy (5 papers), Inflammasome and immune disorders (4 papers) and MicroRNA in disease regulation (3 papers). Gan Qiao is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Inflammasome and immune disorders (4 papers) and MicroRNA in disease regulation (3 papers). Gan Qiao collaborates with scholars based in China, Pakistan and Israel. Gan Qiao's co-authors include Xiukun Lin, Anguo Wu, Huanli Xu, Xiaoliang Chen, Jianming Wu, Dalian Qin, Xiaogang Zhou, Lu Yu, Xiaohui Liu and Betty Yuen Kwan Law and has published in prestigious journals such as Nature Communications, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Gan Qiao

33 papers receiving 751 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gan Qiao China 15 436 166 99 82 75 37 754
Faezeh Ghasemi Iran 12 496 1.1× 195 1.2× 70 0.7× 67 0.8× 75 1.0× 22 993
Fang Shi China 17 363 0.8× 175 1.1× 65 0.7× 49 0.6× 69 0.9× 33 762
Hsiao‐Mei Kuo Taiwan 20 456 1.0× 147 0.9× 90 0.9× 94 1.1× 35 0.5× 43 855
Xiaomei Bao China 14 382 0.9× 107 0.6× 91 0.9× 91 1.1× 55 0.7× 24 801
Guanglin Zhang China 18 393 0.9× 150 0.9× 55 0.6× 66 0.8× 36 0.5× 42 671
Hang Yang China 17 479 1.1× 256 1.5× 169 1.7× 74 0.9× 41 0.5× 27 945
Marianna Abate Italy 10 354 0.8× 100 0.6× 95 1.0× 52 0.6× 28 0.4× 21 684
Soesiawati R. Darjatmoko United States 19 567 1.3× 80 0.5× 95 1.0× 76 0.9× 41 0.5× 34 1.2k

Countries citing papers authored by Gan Qiao

Since Specialization
Citations

This map shows the geographic impact of Gan Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gan Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gan Qiao more than expected).

Fields of papers citing papers by Gan Qiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gan Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gan Qiao. The network helps show where Gan Qiao may publish in the future.

Co-authorship network of co-authors of Gan Qiao

This figure shows the co-authorship network connecting the top 25 collaborators of Gan Qiao. A scholar is included among the top collaborators of Gan Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gan Qiao. Gan Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Qiang, Gan Qiao, Jinyu Cheng, et al.. (2025). De novo designed protein guiding targeted protein degradation. Nature Communications. 16(1). 6598–6598. 3 indexed citations
2.
Wu, Shuang, Xinyue Mei, Qi Xiao, et al.. (2025). Regulating mitochondrial oxidative phosphorylation and MAPK signaling: wedelolactone as a novel therapeutic for radiation-induced thrombocytopenia. Frontiers in Pharmacology. 16. 1508215–1508215. 1 indexed citations
3.
Yang, Huan, Anguo Wu, Yan Guo, et al.. (2025). ALPK1 signaling pathway activation by HMGB1 drives microglial pyroptosis and ferroptosis and brain injury after acute ischemic stroke. International Immunopharmacology. 149. 114229–114229. 4 indexed citations
4.
5.
Zhou, Xiaogang, Jing Wang, Lu Yu, et al.. (2024). Mitophagy and cGAS–STING crosstalk in neuroinflammation. Acta Pharmaceutica Sinica B. 14(8). 3327–3361. 44 indexed citations
6.
Liu, Xingyu, Yi Qing, Gan Qiao, et al.. (2024). Free total rhubarb anthraquinones protect intestinal mucosal barrier of SAP rats via inhibiting the NLRP3/caspase-1/GSDMD pyroptotic pathway. Journal of Ethnopharmacology. 326. 117873–117873. 13 indexed citations
7.
He, Siyu, Sheng Liu, Xinyue Mei, et al.. (2024). A novel therapeutic strategy for leukopenia: Miltefosine activates the Ras/MEK/ERK pathway to promote neutrophil differentiation. Biochemical and Biophysical Research Communications. 746. 151239–151239. 1 indexed citations
8.
Xing, Jinshan, Xin Luo, Shuang Liu, et al.. (2023). Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of asparagus against polycystic ovary syndrome. Journal of Ovarian Research. 16(1). 128–128. 4 indexed citations
9.
Xing, Jinshan, et al.. (2023). Network Pharmacology Analysis and Experimental Pharmacology Study Explore the Mechanism of Asparagus against Glioblastoma. Journal of Food Biochemistry. 2023. 1–11. 1 indexed citations
10.
Li, Qiuting, Gan Qiao, Jianguo Feng, et al.. (2023). Stress-enhanced cardiac lncRNA Morrbid protects hearts from acute myocardial infarction. JCI Insight. 8(16). 10 indexed citations
11.
Luo, Xin, Jinshan Xing, Aharon Gedanken, et al.. (2023). Micelle encapsulation zinc‐doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair. Bioengineering & Translational Medicine. 8(3). e10507–e10507. 10 indexed citations
12.
Wu, Xu, et al.. (2022). Dynamic Monitoring of Immunoinflammatory Response Identifies Immunoswitching Characteristics of Severe Acute Pancreatitis in Rats. Frontiers in Immunology. 13. 876168–876168. 7 indexed citations
13.
Qiao, Gan, et al.. (2022). Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome. Endocrine. 78(3). 615–627. 3 indexed citations
15.
Qiao, Gan, Anguo Wu, Xiaoliang Chen, Ye Tian, & Xiukun Lin. (2021). Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment. International Journal of Biological Sciences. 17(14). 3981–3992. 82 indexed citations
16.
Tao, Hongyu, Huanli Xu, Cong Li, et al.. (2020). <p>Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo</p>. Drug Design Development and Therapy. Volume 14. 3495–3507. 33 indexed citations
17.
Tao, Hongyu, Huanli Xu, Cong Li, et al.. (2020). Exosomes-coated bcl-2 siRNA inhibits the growth of digestive system tumors both in vitro and in vivo. International Journal of Biological Macromolecules. 161. 470–480. 59 indexed citations
18.
Wu, Anguo, Xiaogang Zhou, Gan Qiao, et al.. (2020). Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Ageing Research Reviews. 65. 101202–101202. 154 indexed citations
19.
Tao, Hongyu, et al.. (2020). Alkaloids as Anticancer Agents: A Review of Chinese Patents in Recent 5 Years. Recent Patents on Anti-Cancer Drug Discovery. 15(1). 2–13. 15 indexed citations
20.
Li, Xiao, Huanli Xu, Cong Li, et al.. (2019). Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR Pathway. Frontiers in Pharmacology. 10. 319–319. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026